203 related articles for article (PubMed ID: 23760674)
1. Antitumor properties of a vanadyl(IV) complex with the flavonoid chrysin [VO(chrysin)2EtOH]2 in a human osteosarcoma model: the role of oxidative stress and apoptosis.
Leon IE; Di Virgilio AL; Porro V; Muglia CI; Naso LG; Williams PA; Bollati-Fogolin M; Etcheverry SB
Dalton Trans; 2013 Sep; 42(33):11868-80. PubMed ID: 23760674
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the effect of an oxovanadium(iv) complex with the flavonoid chrysin (VOChrys) on intracellular cell signalling pathways in an osteosarcoma cell line.
León IE; Díez P; Etcheverry SB; Fuentes M
Metallomics; 2016 Aug; 8(8):739-49. PubMed ID: 27175625
[TBL] [Abstract][Full Text] [Related]
3. Role of oxidative stress in the antitumoral action of a new vanadyl(IV) complex with the flavonoid chrysin in two osteoblast cell lines: relationship with the radical scavenger activity.
Naso L; Ferrer EG; Lezama L; Rojo T; Etcheverry SB; Williams P
J Biol Inorg Chem; 2010 Aug; 15(6):889-902. PubMed ID: 20364393
[TBL] [Abstract][Full Text] [Related]
4. Copper(II) Complexes with Saccharinate and Glutamine as Antitumor Agents: Cytoand Genotoxicity in Human Osteosarcoma Cells.
Cadavid-Vargas JF; Leon IE; Etcheverry SB; Santi E; Torre MH; Di Virgilio AL
Anticancer Agents Med Chem; 2017; 17(3):424-433. PubMed ID: 27173967
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antitumor effects of the VO-chrysin complex on a new three-dimensional osteosarcoma spheroids model and a xenograft tumor in mice.
León IE; Cadavid-Vargas JF; Resasco A; Maschi F; Ayala MA; Carbone C; Etcheverry SB
J Biol Inorg Chem; 2016 Dec; 21(8):1009-1020. PubMed ID: 27696106
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative and apoptosis-inducing activity of an oxidovanadium(IV) complex with the flavonoid silibinin against osteosarcoma cells.
Leon IE; Porro V; Di Virgilio AL; Naso LG; Williams PA; Bollati-Fogolín M; Etcheverry SB
J Biol Inorg Chem; 2014 Jan; 19(1):59-74. PubMed ID: 24233155
[TBL] [Abstract][Full Text] [Related]
7. Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model.
León IE; Porro V; Astrada S; Egusquiza MG; Cabello CI; Bollati-Fogolin M; Etcheverry SB
Chem Biol Interact; 2014 Oct; 222():87-96. PubMed ID: 25451568
[TBL] [Abstract][Full Text] [Related]
8. Oxidovanadium(IV) complexes with chrysin and silibinin: anticancer activity and mechanisms of action in a human colon adenocarcinoma model.
León IE; Cadavid-Vargas JF; Tiscornia I; Porro V; Castelli S; Katkar P; Desideri A; Bollati-Fogolin M; Etcheverry SB
J Biol Inorg Chem; 2015 Oct; 20(7):1175-91. PubMed ID: 26404080
[TBL] [Abstract][Full Text] [Related]
9. Hydroxylamido-amino acid complexes of oxovanadium(V). Toxicological study in cell culture and in a zebrafish model.
León IE; Di Virgilio AL; Barrio DA; Arrambide G; Gambino D; Etcheverry SB
Metallomics; 2012 Dec; 4(12):1287-96. PubMed ID: 23073485
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant, DNA cleavage, and cellular effects of silibinin and a new oxovanadium(IV)/silibinin complex.
Naso LG; Ferrer EG; Butenko N; Cavaco I; Lezama L; Rojo T; Etcheverry SB; Williams PA
J Biol Inorg Chem; 2011 Apr; 16(4):653-68. PubMed ID: 21399988
[TBL] [Abstract][Full Text] [Related]
11. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent.
Narla RK; Dong Y; D'Cruz OJ; Navara C; Uckun FM
Clin Cancer Res; 2000 Apr; 6(4):1546-56. PubMed ID: 10778988
[TBL] [Abstract][Full Text] [Related]
12. Biological evaluation of morin and its new oxovanadium(IV) complex as antioxidant and specific anti-cancer agents.
Naso LG; Lezama L; Rojo T; Etcheverry SB; Valcarcel M; Roura M; Salado C; Ferrer EG; Williams PA
Chem Biol Interact; 2013 Nov; 206(2):289-301. PubMed ID: 24125835
[TBL] [Abstract][Full Text] [Related]
13. A new oxidovanadium(IV) complex of oxodiacetic acid and dppz: spectroscopic and DFT study. Antitumor action on MG-63 human osteosarcoma cell line.
León IE; Parajón-Costa BS; Franca CA; Etcheverry SB; Baran EJ
Biol Trace Elem Res; 2015 Apr; 164(2):198-204. PubMed ID: 25534289
[TBL] [Abstract][Full Text] [Related]
14. Vanadium and cancer treatment: antitumoral mechanisms of three oxidovanadium(IV) complexes on a human osteosarcoma cell line.
León IE; Butenko N; Di Virgilio AL; Muglia CI; Baran EJ; Cavaco I; Etcheverry SB
J Inorg Biochem; 2014 May; 134():106-17. PubMed ID: 24199985
[TBL] [Abstract][Full Text] [Related]
15. Spectroscopic characterization of an oxovanadium(IV) complex of oxodiacetic acid and o-phenanthroline. Bioactivity on osteoblast-like cells in culture.
León IE; Etcheverry SB; Parajón-Costa BS; Baran EJ
Biol Trace Elem Res; 2012 Jun; 147(1-3):403-7. PubMed ID: 22246791
[TBL] [Abstract][Full Text] [Related]
16. Bis(oxalato)dioxovanadate(V) and bis(oxalato)oxoperoxo-vanadate(V) complexes: spectroscopic characterization and biological activity.
León IE; Etcheverry SB; Parajón-Costa BS; Baran EJ
Biol Trace Elem Res; 2013 Nov; 155(2):295-300. PubMed ID: 24026441
[TBL] [Abstract][Full Text] [Related]
17. Palladacycle (BPC) antitumour activity against resistant and metastatic cell lines: the relationship with cytosolic calcium mobilisation and cathepsin B activity.
Bechara A; Barbosa CM; Paredes-Gamero EJ; Garcia DM; Silva LS; Matsuo AL; Nascimento FD; Rodrigues EG; Caires AC; Smaili SS; Bincoletto C
Eur J Med Chem; 2014 May; 79():24-33. PubMed ID: 24709226
[TBL] [Abstract][Full Text] [Related]
18. Improving the bioactivity of Zn(II)-curcumin based complexes.
Pucci D; Crispini A; Sanz Mendiguchía B; Pirillo S; Ghedini M; Morelli S; De Bartolo L
Dalton Trans; 2013 Jul; 42(26):9679-87. PubMed ID: 23680928
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, interaction with DNA, cytotoxicity, cell cycle arrest and apoptotic inducing properties of ruthenium(II) molecular "light switch" complexes.
Shobha Devi C; Anil Kumar D; Singh SS; Gabra N; Deepika N; Kumar YP; Satyanarayana S
Eur J Med Chem; 2013 Jun; 64():410-21. PubMed ID: 23665797
[TBL] [Abstract][Full Text] [Related]
20. Biological evaluation of new nickel(II) metallates: Synthesis, DNA/protein binding and mitochondrial mediated apoptosis in human lung cancer cells (A549) via ROS hypergeneration and depletion of cellular antioxidant pool.
Kalaivani P; Saranya S; Poornima P; Prabhakaran R; Dallemer F; Vijaya Padma V; Natarajan K
Eur J Med Chem; 2014 Jul; 82():584-99. PubMed ID: 24946146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
